Zykadia Interactions
There are 726 drugs known to interact with Zykadia (ceritinib), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 399 are major, 315 are moderate, and 12 are minor.
- View all 726 medications that may interact with Zykadia
- View Zykadia alcohol/food interactions (2)
- View Zykadia disease interactions (8)
Most frequently checked interactions
View interaction reports for Zykadia (ceritinib) and the medicines listed below.
- Adriamycin PFS (doxorubicin)
- Afinitor (everolimus)
- Alecensa (alectinib)
- Alimta (pemetrexed)
- alprazolam
- Arixtra 7.5 mg/dose (fondaparinux)
- Arzerra (ofatumumab)
- Avastin (bevacizumab)
- benzonatate
- Bosulif (bosutinib)
- Braftovi (encorafenib)
- Bumex (bumetanide)
- Campath (alemtuzumab)
- carboplatin
- cefadroxil
- cetirizine
- ciprofloxacin ophthalmic
- citalopram
- Cytosar (cytarabine)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Depakote (divalproex sodium)
- dextromethorphan
- Diacomit (stiripentol)
- dicyclomine
- doxylamine
- Mekinist (trametinib)
- Tarceva (erlotinib)
- warfarin
- Xalkori (crizotinib)
Zykadia alcohol/food interactions
There are 2 alcohol/food interactions with Zykadia (ceritinib).
Zykadia disease interactions
There are 8 disease interactions with Zykadia (ceritinib) which include:
- QT prolongation
- bradycardia
- GI complications
- hepatic impairment
- hyperglycemia
- pancreatitis
- renal impairment
- lung toxicity
Report options
QR code containing a link to this page
More about Zykadia (ceritinib)
- Zykadia consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
